BELLADONNA, Maria Laura
 Distribuzione geografica
Continente #
NA - Nord America 4.450
EU - Europa 3.497
AS - Asia 3.301
SA - Sud America 524
AF - Africa 85
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 3
Totale 11.867
Nazione #
US - Stati Uniti d'America 4.332
SG - Singapore 1.466
IT - Italia 912
CN - Cina 486
IE - Irlanda 474
HK - Hong Kong 416
BR - Brasile 403
VN - Vietnam 384
UA - Ucraina 363
RU - Federazione Russa 339
SE - Svezia 270
DE - Germania 262
FR - Francia 223
FI - Finlandia 158
RO - Romania 146
GB - Regno Unito 97
KR - Corea 94
IN - India 93
CA - Canada 64
BD - Bangladesh 61
AR - Argentina 46
BE - Belgio 39
JP - Giappone 37
NL - Olanda 37
TR - Turchia 37
CZ - Repubblica Ceca 32
MX - Messico 30
PL - Polonia 30
CH - Svizzera 28
PK - Pakistan 26
ES - Italia 25
IQ - Iraq 24
ID - Indonesia 23
IR - Iran 22
AT - Austria 20
EC - Ecuador 19
UZ - Uzbekistan 19
ZA - Sudafrica 17
EG - Egitto 16
CO - Colombia 15
JO - Giordania 14
CI - Costa d'Avorio 13
LB - Libano 13
SA - Arabia Saudita 13
VE - Venezuela 12
PH - Filippine 11
GR - Grecia 10
CL - Cile 9
MA - Marocco 9
AE - Emirati Arabi Uniti 8
PY - Paraguay 8
AZ - Azerbaigian 7
EU - Europa 7
IL - Israele 7
TN - Tunisia 7
LT - Lituania 6
OM - Oman 6
KE - Kenya 5
PE - Perù 5
TH - Thailandia 5
BO - Bolivia 4
CR - Costa Rica 4
JM - Giamaica 4
KZ - Kazakistan 4
MY - Malesia 4
PS - Palestinian Territory 4
RS - Serbia 4
AL - Albania 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
GA - Gabon 3
KW - Kuwait 3
PA - Panama 3
AU - Australia 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BH - Bahrain 2
CU - Cuba 2
CV - Capo Verde 2
DZ - Algeria 2
ET - Etiopia 2
GT - Guatemala 2
HU - Ungheria 2
KH - Cambogia 2
MT - Malta 2
NG - Nigeria 2
QA - Qatar 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
AM - Armenia 1
CG - Congo 1
EE - Estonia 1
GD - Grenada 1
GE - Georgia 1
GF - Guiana Francese 1
HN - Honduras 1
HR - Croazia 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
Totale 11.850
Città #
Singapore 1.105
Perugia 519
Chandler 506
Dublin 469
Hong Kong 413
San Jose 346
Ashburn 257
San Mateo 244
Dong Ket 194
Jacksonville 194
Boardman 188
Santa Clara 175
Beijing 131
Moscow 120
Bucharest 118
Redmond 113
Munich 106
Medford 101
Wilmington 101
Princeton 100
Lauterbourg 97
Los Angeles 92
Seoul 90
Ann Arbor 86
Altamura 83
Lawrence 75
New York 72
Ho Chi Minh City 66
The Dalles 58
Andover 57
Des Moines 48
Falls Church 45
Brussels 39
Piscataway 38
Helsinki 36
Orem 35
São Paulo 34
Chennai 33
Council Bluffs 33
Hanoi 31
Dearborn 30
Tokyo 30
Turku 30
Dallas 28
Saint Petersburg 28
Pisa 26
Chicago 25
Warsaw 25
Denver 24
Nuremberg 24
Woodbridge 23
Atlanta 22
Norwalk 22
Poplar 20
Haiphong 18
Ottawa 18
San Paolo di Civitate 18
Brooklyn 17
Fremont 17
Montreal 17
Bologna 16
Boston 16
Brno 15
Frankfurt am Main 15
Milan 15
Stockholm 15
Amsterdam 14
Houston 14
Olomouc 14
Rome 14
Abidjan 13
Columbus 13
Lappeenranta 13
London 13
Toronto 13
Vicenza 13
Măgurele 12
Rio de Janeiro 12
San Francisco 12
Guangzhou 11
Izmir 11
Manchester 11
Phoenix 11
Tashkent 11
Hefei 10
Johannesburg 10
Mexico City 10
Amman 9
Baghdad 9
Belo Horizonte 9
Falkenstein 9
Fortaleza 9
Mumbai 9
Parma 9
Redwood City 9
San Diego 9
Shanghai 9
Vienna 9
Chiajna 8
Istanbul 8
Totale 7.572
Nome #
Class IA PI3Ks regulate subcellular and functional dynamics of IDO1 211
Allosteric modulation of metabotropic glutamate receptor 4 activates IDO1-dependent, immunoregulatory signaling in dendritic cells 204
A GpC-Rich Oligonucleotide Acts on Plasmacytoid Dendritic Cells To Promote Immune Suppression. 203
A Relay Pathway between Arginine and Tryptophan Metabolism Confers Immunosuppressive Properties on Dendritic Cells 200
Amino-acid sensing and degrading pathways in immune regulation 196
Assessment of TILs, IDO-1, and PD-L1 in resected non-small cell lung cancer: an immunohistochemical study with clinicopathological and prognostic implications 193
Aryl hydrocarbon receptor control of a disease tolerance defence pathway. 190
Distinct roles of immunoreceptor tyrosine-based motifs in immunosuppressive indoleamine 2,3-dioxygenase 1. 183
Engagement of Nuclear Coactivator 7 by 3-Hydroxyanthranilic Acid Enhances Activation of Aryl Hydrocarbon Receptor in Immunoregulatory Dendritic Cells 182
Identification of a 2-propanol analogue modulating the non-enzymatic function of indoleamine 2,3-dioxygenase 1 175
Artocarpus tonkinensis extract inhibits LPS-triggered inflammation markers and suppresses RANKL-induced osteoclastogenesis in RAW264.7 161
87P - Towards the identification of the mechanism of action of antitumor 1-methyl-D-tryptophan 158
Beneficial effects of horsetail (Equisetum arvense) in experimental models of sarcopenia and osteoporosis 155
Positive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammation 155
IL‐35Ig–expressing dendritic cells induce tolerance via Arginase 1 153
Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy 148
A retroviral peptide encoded by mutated env p15E gene is recognized by specific CD8+ T lymphocytes on drug-treated murine mastocytoma P815. 147
Dendritic cells expressing ectopic IL-35Ig induce IDO-related tolerance in vivo. 144
Cutting edge: Autocrine TGF-beta sustains default tolerogenesis by IDO-competent dendritic cells. 141
Anti-osteoclastogenic activity of Crocus sativus petal extract: turning saffron waste into a valuable resource against bone disruption. 138
Deficiency of immunoregulatory indoleamine 2,3-dioxygenase 1 in juvenile diabetes 136
The TGF-β/IDO axis in infectious tolerance. 135
Indoleamine 2,3-dioxygenase 2 immunohistochemical expression in a resected non-small cell lung cancer series 132
Immunogenic tumor variants induced by drug treatment of the L5178Y lymphoma: search for serologically defined antigens at the clonal level. 130
Aryl hydrocarbon Receptor and RelB control long term expression of Indoleamine 2,3-dioxygenase-1 in endotoxin tolerance 129
CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86. 128
Antigen-specific immunoregulation by IL-35Ig-transfected dendritic cells 127
Forced IDO1 expression in dendritic cells restores immunoregulatory signalling in autoimmune diabetes 124
Circulating levels of IL-10 are critically related to growth and rejection patterns of murine mastocytoma cells. 122
Ectopic expression of IL-35Ig by dendritic cells induces tolerance via Arginase 1. 120
Novel mutations in the WFS1 gene are associated with Wolfram syndrome and systemic inflammation 119
Indoleamine 2,3-Dioxygenase 2 Immunohistochemical Expression in Resected Human Non-small Cell Lung Cancer: A Potential New Prognostic Tool 118
CTLA-4-Ig activates forkhead transcription factors and protects dendritic cells from oxidative stress in nonobese diabetic mice 116
Evidence for tumor necrosis factor alpha as a mediator of the toxicity of a cyclooxygenase inhibitor in Gram-negative sepsis. 116
Islet antigen-pulsed dendritic cells expressing ectopic IL-35Ig protect nonobese diabetic mice from autoimmune diabetes. 116
Anti-inflammatory and anti-osteoclastogenic activity of a Crocus sativus petal extract targeting macrophages: from waste to raw material on the way to preventing bone loss. Maria 114
Autocrine IL-12 is involved in dendritic cell modulation via CD40 ligation 113
IL-12 acts selectively on CD8a- dendritic cells to enhance presentation of a tumor peptide in vivo 112
Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells 110
IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance 110
KYMASIN UP Natural Product Inhibits Osteoclastogenesis and Improves Osteoblast Activity by Modulating Src and p38 MAPK 108
Epacadostat stabilizes the apo-form of IDO1 and signals a pro-tumorigenic pathway in human ovarian cancer cells 108
Effect of Probiotic Administration on Serum Tryptophan Metabolites in Pediatric Type 1 Diabetes Patients 107
A tumor-associated and self antigen peptide presented by dendritic cells may induce T cell anergy in vivo, but IL-12 can prevent or revert the anergic state 106
Kynurenine/Tryptophan Ratio as a Potential Blood-Based Biomarker in Non-Small Cell Lung Cancer 105
Beneficial effects of horsetail (Equisetum arvense) in in vitro models of sarcopenia and osteoporosis 104
Dendritic cells, interleukin 12, and CD4+ lymphocytes in the initiation of class I-restricted reactivity to a tumor/self peptide. 102
Modulation of tryptophan catabolism by regulatory T cells 101
Adjuvant activities of novel cytokines, interleukin-23 (IL-23) and IL-27, for induction of hepatitis C virus-specific cytotoxic T lymphocytes in HLA-A*0201 transgenic mice. 101
The catalytic inhibitor epacadostat can affect the non-enzymatic function of IDO1 100
Immunosuppression via tryptophan catabolism: the role of kynurenine pathway enzymes. 100
Pathogenetic Interplay Between IL-6 and Tryptophan Metabolism in an Experimental Model of Obesity 100
CD40 ligation ablates the tolerogenic potential of lymphoid dendritic cells 99
Crocus sativus L. Petal Extract Inhibits Inflammation and Osteoclastogenesis in RAW 264.7 Cell Model 99
Equisetum arvense standardized dried extract hinders age-related osteosarcopenia. 97
IL-6 inhibits the tolerogenic function of CD8 alpha+ dendritic cells expressing indoleamine 2,3-dioxygenase. 97
Cutting edge: silencing suppressor of cytokine signaling 3 expression in dendritic cells turns CD28-Ig from immune adjuvant to suppressant. 97
High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9-TRIF pathway. 97
The signaling function of IDO1 incites the malignant progression of mouse B16 melanoma 96
Multiple point mutations in an endogenous retroviral gene confer high immunogenicity on a drug-treated murine 96
High PD-L1/IDO-2 and PD-L2/IDO-1 Co-Expression Levels Are Associated with Worse Overall Survival in Resected Non-Small Cell Lung Cancer Patients 96
Indoleamine 2,3-dioxygenase, transcriptional regulation and autoimmunity. 94
Bioengineering heterodimeric cytokines: turning promiscuous proteins into therapeutic agents. 94
CTLA-4-Ig regulates tryptophan catabolism in vivo. 93
Ectopic expression of IL-35Ig by dendritic cells induces IDO-related tolerance in vivo 92
Current Challenges for IDO2 as Target in Cancer Immunotherapy 92
Functional expression of indoleamine 2,3-dioxygenase by murine CD8 alpha(+) dendritic cells. 91
Positive regulatory role of IL-12 in macrophages and modulation by IFN-gamma 90
Interleukin-23 and interleukin-27 exert quite different antitumor and vaccine effects on poorly immunogenic melanoma. 90
Potential prognostic role of Indoleamine 2,3-dioxygenase 2 in human non-small cell lung cancer: an immunohistochemical study. 89
IL-23 neutralization protects mice from Gram-negative endotoxic shock. 89
Cinnabarinic acid, an endogenous agonist of type-4 metabotropic glutamate receptor, suppresses experimental autoimmune encephalomyelitis in mice. 89
IL-12 ACTS DIRECTLY ON DC TO PROMOTE NUCLEAR LOCALIZATION OF NF-kB AND PRIMES DC FOR IL-12 PRODUCTION 88
Effects of IL-12 and IL-23 on antigen-presenting cells at the interface between innate and adaptive immunity. 87
The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells 86
Tryptophan catabolism generates autoimmune-preventive regulatory T cells 85
IL-12 induces SDS-stable class II (alpha beta) dimers in murine dendritic cells 85
METODO PER LA REALIZZAZIONE DI UNA COMPOSIZIONE PER USO FARMACEUTICO COMPRENDENTE CELLULE DENDRITICHE E COMPOSIZIONE PER USO FARMACEUTICO COSI' OTTENUTA 85
The Proteasome Inhibitor Bortezomib Controls Indoleamine 2,3-Dioxygenase 1 Breakdown and Restores Immune Regulation in Autoimmune Diabetes. 85
The role of TGF-beta as tolerogenic cytokine in regulating dendritic cell function. 85
Membrane Localization and Phosphorylation of Indoleamine 2,3-Dioxygenase 2 (IDO2) in A549 Human Lung Adenocarcinoma Cells: First Steps in Exploring Its Signaling Function 84
Interleukin-23-expressing bone marrow-derived neural stem-like cells exhibit antitumor activity against intracranial glioma. 84
Negative vaccination with IGRP-pulsed dendritic cells expressing ectopic IL-35Ig prevents the development of NOD autoimmune Diabetes 84
Sensing of an HIV-1-Derived Single-Stranded RNA-Oligonucleotide Induces Arginase 1-Mediated Tolerance 82
SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis 82
IL-23 and IL-12 have overlapping but distinct effects on murine dendritic cells. 81
Dendritic cells, CD4+ lymphocytes and IL-12 in an experimental model of antitumor immunotherapy 80
Endogenous retroviral gp70 genes of the murine lymphoma L5178Y: analysis of restriction fragment polymorphism upon induction of drug-mediated immunogenicity. 80
The IL-23/IL-17 pathway impairs antifungal immune resistance 79
PRODUCTION OF MEMBRANE AND SOLUBLE PD-L1 BY LUNG TUMOR CELLS 79
Immunogenic properties of retroviral protein p15E from drug-treated murine mastocytoma P815 78
T-bet is a critical determinant in the instability of the IL-17-secreting T-helper phenotype. 78
Kynurenine pathway enzymes in dendritic cells initiate tolerogenesis in the absence of functional IDO. 77
IL-23 enhances host defense against vaccinia virus infection via a mechanism partly involving IL-17. 77
Immunogenicity of tumor peptides: importance of peptide length and stability of peptide/MHC class II complex 76
Endotoxin tolerance as a novel defense strategy in infectious diseases: the role of tryptophan catabolism 76
Potentent antitumor activity of interleukin-27. 74
IL-12 is both required and sufficient for initiating T-cell reactivity to a class I-restricted tumor peptide (P815AB) following transfer of P815AB-pulsed dendritic cells 73
Expression of interleukins-23 and 27 leads to successful gene therapy of hepatocellular carcinoma. 72
Induction of potent antitumor immunity by intratumoral injection of interleukin 23-transduced dendritic cells. 71
Totale 11.236
Categoria #
all - tutte 49.989
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.989


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021209 0 0 0 0 0 0 0 0 0 0 0 209
2021/20221.242 19 179 20 48 55 31 14 276 153 102 117 228
2022/20231.660 112 283 12 153 151 173 1 81 611 17 49 17
2023/2024757 37 92 25 11 11 12 199 22 77 19 88 164
2024/20251.958 47 155 148 118 206 88 128 207 300 109 269 183
2025/20264.375 269 294 237 619 523 415 701 304 426 363 135 89
Totale 12.225